A Phase I/II Study Of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Trial Profile

A Phase I/II Study Of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 04 Oct 2017 Status changed from recruiting to completed.
    • 13 Sep 2017 The study has been been completed in Hungary (End date: 2017-08-21)
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top